Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

CoreMap, a US-based developer of a cure for atrial fibrillation spun out of University of Vermont, has concurrently completed a $3m series A extension and $20m series B round from undisclosed strategic, institutional, venture and individual investors. CoreMap previously raised an initial $10.5m in series A financing led by Qure Ventures, with participation from The…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.

Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Talking Tech Transfer interview podcast and responsible for the monthly GUV Gazette (sign up here for free).